Methestrol dipropionate
Methestrol dipropionate (also known as promethestrol dipropionate and dienestrol dipropionate) is a synthetic, nonsteroidal estrogen of the stilbestrol group that was formerly used in medicine but has since been discontinued. It is an estrogen ester – specifically, the 3,17-dipropionate ester of methestrol (dienestrol) – and acts as a prodrug of methestrol in the body. Methestrol dipropionate is administered by injection and is used for indications such as the treatment of menopausal symptoms and gynecological disorders.
History[edit]
Methestrol dipropionate was first described in the literature in 1949 and was introduced for medical use by 1951. It was used in the United States and Europe but was withdrawn in many countries in the 1970s due to safety concerns.
Medical uses[edit]
Methestrol dipropionate was used in the treatment of menopausal symptoms, gynecological disorders, and certain hormone-sensitive cancers. It was also used to support pregnancy in women with a history of recurrent miscarriage.
Pharmacology[edit]
As a prodrug of methestrol, methestrol dipropionate has estrogenic activity. It is administered by injection, and once in the body, it is cleaved by esterases into methestrol and propionic acid.
Side effects[edit]
The side effects of methestrol dipropionate are similar to those of other estrogens. These may include nausea, breast tenderness, menstrual irregularities, and fluid retention. In addition, there is a risk of thromboembolism and other serious cardiovascular side effects.
Society and culture[edit]
Methestrol dipropionate was marketed under a variety of brand names including Honvol, Improvil, and Synthoestrin, among others. It is no longer available in any country.
See also[edit]
-
Methestrol dipropionate
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
